Optima Health plc (AIM:OPT)
London · Delayed Price · Currency is GBP · Price in GBX 244.00
0.00 (0.00%)
At close: Sep 4, 2026
Optima Health Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 120.64 | 105.05 | 110.89 | 115.35 | 22.39 | |
Revenue Growth | 14.84% | -5.27% | -3.87% | 415.27% | - |
Cost of Revenue | 85.26 | 72.01 | 74.41 | 78.41 | 14.35 |
Gross Profit | 35.38 | 33.04 | 36.47 | 36.94 | 8.04 |
Selling, General & Admin | 24.41 | 19.57 | 22.92 | 16.09 | 5.06 |
Amortization of Goodwill & Intangibles | 6.76 | 6.32 | 6.31 | - | - |
Other Operating Expenses | - | - | - | -0.2 | - |
Operating Expenses | 31.41 | 25.93 | 29.23 | 26.11 | 7.3 |
Operating Income | 3.97 | 7.11 | 7.25 | 10.83 | 0.74 |
Interest Expense | -1.43 | -0.67 | -0.14 | -0.13 | -0.02 |
Interest & Investment Income | 0.06 | - | - | 0 | 0 |
Other Non Operating Income (Expenses) | -0.14 | - | - | - | - |
EBT Excluding Unusual Items | 2.47 | 6.45 | 7.11 | 10.7 | 0.73 |
Merger & Restructuring Charges | -4.69 | -1.49 | -8.57 | -5.95 | -1.24 |
Legal Settlements | 4.7 | - | - | - | - |
Other Unusual Items | - | -2.38 | 0.6 | -4.04 | - |
Pretax Income | 2.47 | 2.58 | -0.86 | 0.71 | -0.51 |
Income Tax Expense | 1.07 | 0.92 | 0.23 | -0.88 | -0.27 |
Net Income | 1.4 | 1.65 | -1.08 | 1.59 | -0.25 |
Net Income to Common | 1.4 | 1.65 | -1.08 | 1.59 | -0.25 |
Net Income Growth | -15.01% | - | - | - | - |
Shares Outstanding (Basic) | 89 | 52 | - | - | - |
Shares Outstanding (Diluted) | 89 | 52 | - | - | - |
Shares Change | 72.93% | - | - | - | - |
EPS (Basic) | 0.02 | 0.03 | - | - | - |
EPS (Diluted) | 0.02 | 0.03 | - | - | - |
EPS Growth | -47.55% | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 14.15 | 0.89 | 12.44 | 5.18 | -1.15 |
Free Cash Flow Per Share | 0.16 | 0.02 | - | - | - |
Gross Margin | 29.33% | 31.45% | 32.89% | 32.02% | 35.92% |
Operating Margin | 3.29% | 6.77% | 6.54% | 9.39% | 3.32% |
Profit Margin | 1.16% | 1.57% | -0.98% | 1.38% | -1.10% |
Free Cash Flow Margin | 11.73% | 0.85% | 11.22% | 4.49% | -5.15% |
EBITDA | 10.26 | 12.81 | 13.09 | 16.62 | 2.21 |
EBITDA Margin | 8.50% | 12.20% | 11.80% | 14.41% | 9.87% |
D&A For EBITDA | 6.29 | 5.7 | 5.84 | 5.8 | 1.47 |
EBIT | 3.97 | 7.11 | 7.25 | 10.83 | 0.74 |
EBIT Margin | 3.29% | 6.77% | 6.54% | 9.39% | 3.32% |
Effective Tax Rate | 43.20% | 35.84% | - | - | - |